31
Participants
Start Date
January 31, 2009
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
PET/CT
Patients receive F-18-ISO-1 i.v. and undergo PET/CT imaging at 2-3 time points following the injection.
Laboratory Testing
Blood and urine samples for laboratory analysis and radioactive counts will be obtained during the imaging sessions
Safety Testing
ECG tracings, and vital signs (blood pressure, heart rate, body temperature and respiration rate) are obtained at several time points before, during, and after the imaging sessions.
Immunohistochemistry staining
If available tissue from a biopsy or surgery will be tested cellular proliferation markers such as Ki67 and sigma 2 receptors
F-18-ISO
Patients receive F-18-ISO-1 i.v.
Washington University / Barnes Jewish Hospital, St Louis
Collaborators (1)
Isotrace Technologies
UNKNOWN
Washington University School of Medicine
OTHER